DE59000232D1 - Arzneimittel mit kontrollierter wirkstoffabgabe. - Google Patents

Arzneimittel mit kontrollierter wirkstoffabgabe.

Info

Publication number
DE59000232D1
DE59000232D1 DE9090101675T DE59000232T DE59000232D1 DE 59000232 D1 DE59000232 D1 DE 59000232D1 DE 9090101675 T DE9090101675 T DE 9090101675T DE 59000232 T DE59000232 T DE 59000232T DE 59000232 D1 DE59000232 D1 DE 59000232D1
Authority
DE
Germany
Prior art keywords
active substances
controlled delivery
active ingredient
medicinal products
enveloped
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE9090101675T
Other languages
English (en)
Inventor
Manfred Dipl Ing Buecheler
Andreas Dr Ohm
Roland Dr Rupp
Di Schmoll
Axel Dr Wollenschlaeger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6373866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE59000232(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of DE59000232D1 publication Critical patent/DE59000232D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
DE9090101675T 1989-02-11 1990-01-28 Arzneimittel mit kontrollierter wirkstoffabgabe. Expired - Lifetime DE59000232D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3904093 1989-02-11

Publications (1)

Publication Number Publication Date
DE59000232D1 true DE59000232D1 (de) 1992-09-10

Family

ID=6373866

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9090101675T Expired - Lifetime DE59000232D1 (de) 1989-02-11 1990-01-28 Arzneimittel mit kontrollierter wirkstoffabgabe.

Country Status (15)

Country Link
US (1) US5204121A (de)
EP (1) EP0386440B1 (de)
JP (1) JPH02300126A (de)
AT (1) ATE79029T1 (de)
AU (1) AU622273B2 (de)
CA (1) CA2009736A1 (de)
DE (1) DE59000232D1 (de)
DK (1) DK0386440T3 (de)
ES (1) ES2044246T3 (de)
GR (1) GR3005664T3 (de)
HU (1) HU206044B (de)
IE (1) IE900470L (de)
IL (1) IL93315A0 (de)
NZ (1) NZ232430A (de)
ZA (1) ZA90971B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
DE4319760A1 (de) * 1993-06-15 1994-12-22 Bayer Ag Ipsapiron Arzneimittelzubereitung
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
US5532014A (en) * 1995-08-16 1996-07-02 Townsend Engineering Company Method of linking a strand of uncased coextruded meat emulsion product
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5843504A (en) * 1996-10-15 1998-12-01 Townsend Engineering Company Method and apparatus for coagulating the outer surface of a sausage strand discharged from a sausage extruding machine
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5938520A (en) * 1997-04-10 1999-08-17 Townsend Engineering Company Conveyor for supporting sausage strands during coagulation cycle, and method of rinsing and drying the same
JPH1147581A (ja) * 1997-07-30 1999-02-23 Takasago Internatl Corp 徐放性カプセル及びその製造方法
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
BR9903490A (pt) * 1998-12-15 2000-09-26 Oscar Gold Processo para a preparação de composições farmacêuticas de liberação programada contendo nimodipine, que permitem a liberação gradual e a manuntenção da ação terapeutica
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
KR100574213B1 (ko) * 2000-01-27 2006-04-27 다나베 세이야꾸 가부시키가이샤 서방성 제제 및 그의 제조 방법
KR100790056B1 (ko) 2000-09-06 2007-12-31 미쯔비시 웰 파마 가부시키가이샤 경구용 입제제(粒製劑)
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
AUPR839001A0 (en) * 2001-10-19 2001-11-15 Eli Lilly And Company Dosage form, device and methods of treatment
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
JP5069395B2 (ja) * 2002-02-21 2012-11-07 ヴァレアント インターナショナル （バルバドス） エスアールエル トラマドールの少なくとも１つの形の放出が改良された医薬組成物
US6960346B2 (en) * 2002-05-09 2005-11-01 University Of Tennessee Research Foundation Vehicles for delivery of biologically active substances
WO2003097598A1 (fr) * 2002-05-16 2003-11-27 Shionogi & Co., Ltd. Composé comprenant un antagonisme du récepteur de pdg2
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040228830A1 (en) * 2003-01-28 2004-11-18 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
US8193112B2 (en) * 2008-11-24 2012-06-05 University Of Lethbridge Catalysts for the polymerization of cyclic esters
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
CA2782285A1 (en) 2009-12-02 2011-06-09 Luigi Mapelli Fexofenadine microcapsules and compositions containing them
MX2014013320A (es) 2012-05-07 2015-08-10 Bayer Pharma AG Procedimiento de fabricacion de una forma de dosificacion farmaceutica que comprende nifedipina y candesartan cilexetilo.
CN112592311B (zh) * 2021-01-03 2023-01-31 迪沙药业集团有限公司 一种硝苯地平a晶块状晶习及其控释片组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
EP0250374B1 (de) * 1986-06-17 1991-05-02 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. Therapeutisches System mit geregelter Wirkstoffabgabe
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
GB8703323D0 (en) 1987-02-13 1987-03-18 British Petroleum Co Plc Separation process
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒

Also Published As

Publication number Publication date
GR3005664T3 (de) 1993-06-07
ATE79029T1 (de) 1992-08-15
HU206044B (en) 1992-08-28
ES2044246T3 (es) 1994-01-01
US5204121A (en) 1993-04-20
DK0386440T3 (da) 1992-09-14
JPH02300126A (ja) 1990-12-12
AU622273B2 (en) 1992-04-02
HUT57585A (en) 1991-12-30
EP0386440B1 (de) 1992-08-05
IL93315A0 (en) 1990-11-29
CA2009736A1 (en) 1990-08-11
NZ232430A (en) 1991-10-25
IE900470L (en) 1990-08-11
ZA90971B (en) 1990-11-28
AU4927090A (en) 1990-11-01
EP0386440A1 (de) 1990-09-12
HU900749D0 (en) 1990-04-28

Similar Documents

Publication Publication Date Title
DE59000232D1 (de) Arzneimittel mit kontrollierter wirkstoffabgabe.
DE69434479D1 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
NL194577B (nl) Preparaat voor de lang aanhoudende en gecontroleerde afgifte van medicamenteuze stoffen.
ES2053981T3 (es) Composicion de revestimiento farmaceutica de base acuosa para formas de dosificacion.
DE3684446D1 (de) Arzneimittel mit verzoegerter stossweiser freisetzung.
ATE68969T1 (de) Im magen verbleibende granula.
DE69109557T2 (de) Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm.
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
EP0327295A3 (de) Tetracyclin-Dosisform
DE69004214D1 (de) Arzneimittel mit verzögerter freisetzung und ph-gesteuerten membranüberzügen.
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE3865631D1 (de) Darreichungsform mit kontrollierter freigabe.
MX9202778A (es) Sistema de envasado y composicion adecuada para ser envasada en dicho sistema.
DE68913979D1 (de) Kationenaustauscherharze und carboxylgruppenhaltige Kunstharze enthaltende Arzneizubereitungen mit verzögerter Wirkstofffreisetzung.
DE69106154D1 (de) Verzögerte Freisetzung mit hoch- und niedrigviskoser HPMC.
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
ATE79026T1 (de) Feste pharmazeutische retardform.
DK616186D0 (da) Farmaceutisk praeparat med retarderet frigivelse af ibuprofen
DE69534283D1 (de) Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe
ATE220547T1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
NO942303D0 (no) Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav
GB2282967B (en) Composition containing fructose and plant extracts, for use in preventing and treating the after effects of excessive alcohol intake
DE3267020D1 (en) Benzotriazoles, their preparation and use as medicines
DE68906132D1 (de) Flecainidacetat enthaltende arzneizubereitung mit verzoegerter wirkstofffreigabe.
AU1992392A (en) Monospecific antibodies and antisera to the regulatory subunit of proline-directed protein kinase

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation